Followers | 67 |
Posts | 4831 |
Boards Moderated | 0 |
Alias Born | 06/12/2014 |
Friday, November 01, 2019 10:30:29 AM
Medibio CEO David Kaysen and Jennifer Solitario, SVP Corporate Health, joined the sold out Garmin Digital Health Summit APAC last week in Taipei. From the behind the scenes experience at the Garmin factory, to the Summit presentations, it was two days of learning, connecting, and sharing ideas around wearable technology and the next generation of health metrics.
Highlights from the presentations and conversations:
Employers and Insurers are looking for next-generation health metrics.
Specifically those working in corporate wellness are looking for solutions that are rooted in science, and address mental wellbeing as part of an individual’s overall wellbeing. Scott Montgomery, CEO of WellteQ, presented their digital wellness platform to a packed room, highlighting their newly formed partnership with Medibio. The combined team was energized to speak to so many attendees interested in the work we are doing together to develop an MVP integrated to the WellteQ platform.
Moving from Pilots to Commercialization
There was transparent discussion about moving pilots to commercial programs, with many sharing their experiences about the length of time required to secure commercial contracts. David Kaysen, CEO of Medibio, was honored to participate in the panel discussion Beyond piloting: Long-term commercial success with digital health solutions. He shared lessons learned from piloting our corporate health solution ilumen™, and the forward vision for our work.
What’s the impact of wearables?
Wearables can empower an individual and give them the ability to live a healthier life, especially with early screening of and managing chronic conditions. The power of collaboration and partnership in this area was a consistent conversation in Taipei, as it was at the September European Summit in Amsterdam. We look forward to these continued conversations as we work to aid in early screening and detection of mental health conditions.
https://medibio.com.au/wearables-next-generation-health-metrics/
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM